Maintenance therapies for multiple myeloma

Author:

Mahony Helen1,Kumar Ambuj1,Mhaskar Rahul1,Miladinovic Branko1,Wheatley Keith2,Djulbegovic Benjamin3

Affiliation:

1. University of South Florida; Center for Evidence Based Medicine and Health Outcomes Research; 12901 Bruce B. Downs Blvd MDC 27 Tampa Florida USA 33612

2. University of Birmingham; Cancer Research Clinical Trials Unit, School of Cancer Sciences; Edgbaston Birmingham UK B15 2TT

3. University of South Florida & Mofftt Cancer Center; USF Program for Comparative Effectiveness Research & Dpt of Hematology, Moffitt Cancer Ctr; Tampa Florida USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference42 articles.

1. American Cancer Society Multiple Myeloma Overview, September 2011 http://www.cancer.org/Cancer/MultipleMyeloma/OverviewGuide/multiple-myeloma-overview-key-statistics

2. American Cancer Society Multiple Myeloma Guide, January 2012 http://www.cancer.org/Cancer/MultipleMyeloma/DetailedGuide/multiple-myeloma-survival-rates

3. Southwest Oncology Group Study - Remission maintenance therapy for multiple myeloma;Alexanian;Archives of Internal Medicine,1975

4. Clinically relevant end points and new drug approvals for myeloma;Anderson;Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK,2008

5. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma;Attal;Blood,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3